MTNB
Matinas Biopharma Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.65
+0.01 ▲ +1.35%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$0.64
+0.00 -0.62%
| Index | - | P/E | - | EPS (ttm) | -3.41 | Insider Own | 18.82% | Shs Outstand | 0.01B | Perf Week | 7.59% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | 4.43% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 7.06% | Short Float | 0.09% | Perf Quarter | -18.15% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.14 | Perf Half Y | -64.08% |
| Sales | 0.00B | P/B | 0.59 | EPS next 5Y | - | ROA | -115.51% | Short Interest | 0.00M | Perf YTD | 10.34% |
| Book/sh | 1.09 | P/C | 0.75 | EPS past 3/5Y | 4% 4.58% | ROE | -157.24% | 52W High | -79.07% ($3.09) | Perf Year | 22.42% |
| Cash/sh | 0.86 | P/FCF | - | Sales past 3/5Y | - | ROIC | -220.12% | 52W Low | 36.18% ($0.47) | Perf 3Y | -97.1% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 25.19% | Gross Margin | - | Volatility(W/M) | 5.15% 6.28% | Perf 5Y | -98.92% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | -98.28% |
| Dividend Ex-Date | - | Quick Ratio | 3.78 | EPS Q/Q | 53.39% | Profit Margin | - | RSI (14) | 55.22 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.78 | Sales Q/Q | - | SMA20 | 5.59% ($0.62) | Beta | 1.32 | Target Price | $30 |
| Payout | - | Debt/Eq | 0.36 | Earnings | - | SMA50 | 2.14% ($0.64) | Rel Volume | 0.26 | Prev Close | $0.64 |
| Employees | 7 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | 19.43% - | SMA200 | -40.93% ($1.1) | Avg Volume(3M) | 0.03M | Price | $0.65 |
| IPO | 2014/7/21 | Option/Short | No/Yes | Trades | 109 | Volume | 8,166 | Change | 1.35% |
뉴스 로딩 중...